T1	tradename 0 6	BEXXAR
T3	activeingredient 8 19	tositumomab
T5	nanoparticle 24 49	iodine I 131 tositumomab)
T7	tradename 157 163	BEXXAR
T9	tradename 226 241	BEXXAR. BEXXAR
T11	activeingredient 243 254	tositumomab
T13	nanoparticle 259 284	iodine I 131 tositumomab)
T15	routeofadministration 300 311	intravenous
T17	fdaapprovaldate 344 348	2003
T19	adversereaction 528 547	Allergic Reactions:
T21	tradename 611 617	BEXXAR
T23	adversereaction 650 668	allergic reactions
T25	tradename 733 739	BEXXAR
T27	tradename 935 941	BEXXAR
T29	tradename 1550 1556	BEXXAR
T31	activeingredient 1558 1569	tositumomab
T33	nanoparticle 1574 1599	Iodine I 131 tositumomab)
T35	chemoclass 1605 1618	CD20-directed
T37	indication 1768 1786	Hodgkin's lymphoma
T39	indication 1887 1910	non-Hodgkin's lymphoma.
T41	tradename 1960 1966	BEXXAR
T43	tradename 2113 2119	BEXXAR
T45	tradename 2202 2208	BEXXAR
T47	tradename 2408 2414	BEXXAR
T49	activeingredient 2603 2614	Tositumomab
T51	activeingredient 2668 2679	Tositumomab
T53	nanoparticle 2732 2756	Iodine I 131 tositumomab
T55	activeingredient 2787 2797	Iodine-131
T57	activeingredient 2869 2880	tositumomab
T59	nanoparticle 2942 2966	Iodine I 131 tositumomab
T61	activeingredient 2999 3009	Iodine-131
T63	activeingredient 3078 3089	tositumomab
T65	tradename 3496 3502	BEXXAR
T67	adversereaction 4127 4138	neutropenia
T69	adversereaction 4140 4156	thrombocytopenia
T71	adversereaction 4158 4164	anemia
T73	adversereaction 4166 4176	infections
T75	adversereaction 4178 4196	infusion reactions
T77	adversereaction 4198 4206	asthenia
T79	adversereaction 4208 4213	fever
T81	adversereaction 4219 4226	nausea.
T83	company 4280 4295	GlaxoSmithKline
T85	tradename 6623 6629	BEXXAR
T87	tradename 6766 6772	BEXXAR
T89	tradename 6945 6951	BEXXAR
T91	tradename 7097 7103	BEXXAR
T93	tradename 7391 7397	BEXXAR
T95	tradename 7527 7533	BEXXAR
T97	tradename 7825 7831	BEXXAR
T99	indication 7961 7983	Non-Hodgkin's Lymphoma
T101	tradename 7989 7995	BEXXAR
T103	nanoparticle 8018 8029	tositumomab
T105	activeingredient 8034 8046	iodine I 131
T107	nanoparticle 8047 8059	tositumomab)
T109	indication 8184 8206	non-Hodgkin's lymphoma
T111	indication 8307 8330	non-Hodgkin's lymphoma.
T113	tradename 8375 8381	BEXXAR
T115	tradename 8528 8534	BEXXAR
T117	tradename 8623 8629	BEXXAR
T119	tradename 8756 8762	BEXXAR
T121	tradename 8815 8821	BEXXAR
T123	indication 8918 8941	non-Hodgkin's lymphoma.
T125	tradename 8977 8983	BEXXAR
T127	nanoparticle 9039 9050	tositumomab
T129	activeingredient 9058 9070	iodine I 131
T131	nanoparticle 9071 9083	tositumomab)
T133	nanoparticle 9449 9460	Tositumomab
T135	dose 9461 9467	450 mg
T137	routeofadministration 9471 9482	intravenous
T139	nanoparticle 9499 9516	I-131 tositumomab
T141	dose 9518 9529	5 mCi I-131
T143	routeofadministration 9552 9563	intravenous
T145	nanoparticle 9650 9661	Tositumomab
T147	dose 9662 9668	450 mg
T149	routeofadministration 9672 9683	intravenous
T151	nanoparticle 9701 9718	I-131 tositumomab
T153	dose 9720 9726	35 mg)
T155	routeofadministration 9730 9741	intravenous
T157	activeingredient 9756 9766	iodine-131
T159	activeingredient 10062 10072	Iodine-131
T161	activeingredient 10232 10242	Iodine-131
T163	nanoparticle 10342 10353	Tositumomab
T165	nanoparticle 10540 10551	tositumomab
T167	dose 10573 10579	450 mg
T169	nanoparticle 10580 10591	tositumomab
T171	nanoparticle 10793 10804	tositumomab
T173	nanoparticle 10922 10933	tositumomab
T175	nanoparticle 11062 11079	I-131 Tositumomab
T177	nanoparticle 11334 11351	I-131 tositumomab
T179	nanoparticle 11442 11459	I-131 tositumomab
T181	nanoparticle 11583 11600	I-131 tositumomab
T183	nanoparticle 11801 11818	I-131 tositumomab
T185	activeingredient 12079 12090	Iodine-131.
T187	nanoparticle 12300 12317	I-131 tositumomab
T189	nanoparticle 12423 12440	I-131 tositumomab
T191	nanoparticle 12566 12577	tositumomab
T193	nanoparticle 12673 12690	I-131 tositumomab
T195	nanoparticle 12808 12819	tositumomab
T197	nanoparticle 12897 12908	tositumomab
T199	tradename 13920 13921	 
T201	nanoparticle 13921 13932	Tositumomab
T203	dose 14083 14089	450 mg
T205	nanoparticle 14090 14101	tositumomab
T207	routeofadministration 14135 14146	intravenous
T209	tradename 14599 14600	 
T211	nanoparticle 14600 14611	Tositumomab
T213	activeingredient 14661 14666	I-131
T215	nanoparticle 14667 14678	tositumomab
T217	activeingredient 14836 14841	I-131
T219	nanoparticle 14842 14853	tositumomab
T221	activeingredient 14912 14917	I-131
T223	nanoparticle 14918 14929	tositumomab
T225	nanoparticle 14987 14998	tositumomab
T227	activeingredient 15323 15328	I-131
T229	nanoparticle 15329 15340	tositumomab
T231	activeingredient 15905 15910	I-131
T233	nanoparticle 15911 15922	tositumomab
T235	activeingredient 15989 16001	Iodine I-131
T237	nanoparticle 16002 16013	tositumomab
T239	activeingredient 16253 16258	I-131
T241	nanoparticle 16260 16271	tositumomab
T243	company 16344 16359	GlaxoSmithKline
T245	nanoparticle 16558 16569	tositumomab
T247	company 18471 18486	GlaxoSmithKline
T249	tradename 18487 18493	BEXXAR
T251	company 18658 18673	GlaxoSmithKline
T253	activeingredient 18777 18787	Iodine-131
T255	nanoparticle 18898 18909	Tositumomab
T257	dose 18913 18919	450-mg
T259	nanoparticle 18928 18939	tositumomab
T261	tradename 19023 19024	 
T263	nanoparticle 19025 19042	I-131 tositumomab
T265	nanoparticle 19260 19277	I-131 tositumomab
T267	nanoparticle 19367 19384	I-131 tositumomab
T269	activeingredient 19506 19511	I-131
T271	nanoparticle 19512 19523	tositumomab
T273	activeingredient 19691 19696	I-131
T275	nanoparticle 19697 19708	tositumomab
T277	activeingredient 19876 19881	I-131
T279	nanoparticle 19882 19893	tositumomab
T281	activeingredient 20151 20162	Iodine-131.
T283	activeingredient 20406 20411	I-131
T285	nanoparticle 20412 20423	tositumomab
T287	activeingredient 20536 20541	I-131
T289	nanoparticle 20542 20553	tositumomab
T291	activeingredient 20602 20607	I-131
T293	nanoparticle 20612 20623	tositumomab
T295	nanoparticle 20715 20726	tositumomab
T297	activeingredient 20810 20815	I-131
T299	nanoparticle 20816 20827	tositumomab
T301	nanoparticle 20925 20936	tositumomab
T303	nanoparticle 20996 21007	tositumomab
T305	nanoparticle 21103 21114	tositumomab
T307	nanoparticle 21661 21672	Tositumomab
T309	dose 21811 21817	450 mg
T311	nanoparticle 21818 21829	tositumomab
T313	routeofadministration 21863 21874	intravenous
T315	tradename 22314 22315	 
T317	activeingredient 22315 22320	I-131
T319	nanoparticle 22321 22332	Tositumomab
T321	activeingredient 22379 22384	I-131
T323	nanoparticle 22385 22396	tositumomab
T325	activeingredient 22548 22553	I-131
T327	nanoparticle 22554 22565	tositumomab
T329	activeingredient 22620 22625	I-131
T331	nanoparticle 22626 22637	tositumomab
T333	nanoparticle 22695 22706	tositumomab
T335	activeingredient 23024 23029	I-131
T337	nanoparticle 23030 23041	tositumomab
T339	activeingredient 23606 23611	I-131
T341	nanoparticle 23612 23623	tositumomab
T343	activeingredient 23693 23705	Iodine I-131
T345	nanoparticle 23706 23717	tositumomab
T347	activeingredient 23904 23909	I-131
T349	nanoparticle 23910 23921	tositumomab
T351	tradename 24198 24204	BEXXAR
T353	tradename 24308 24314	BEXXAR
T355	tradename 24355 24361	BEXXAR
T357	tradename 25155 25156	 
T359	nanoparticle 25156 25167	Tositumomab
T361	nanoparticle 25217 25228	Tositumomab
T363	nanoparticle 25283 25294	tositumomab
T365	activeingredient 25325 25335	Iodine-131
T367	nanoparticle 25438 25449	tositumomab
T369	nanoparticle 25538 25549	tositumomab
T371	activeingredient 25582 25592	Iodine-131
T373	nanoparticle 25692 25703	tositumomab
T375	tradename 25903 25909	BEXXAR
T377	tradename 26449 26455	BEXXAR
T379	tradename 26579 26585	BEXXAR
T381	tradename 26720 26726	BEXXAR
T383	tradename 27121 27127	BEXXAR
T385	tradename 27342 27348	BEXXAR
T387	activeingredient 27378 27389	Iodine-131.
T389	tradename 27552 27558	BEXXAR
T391	tradename 27748 27754	BEXXAR
T393	tradename 27902 27908	BEXXAR
T395	tradename 27964 27970	BEXXAR
T397	tradename 28164 28170	BEXXAR
T399	tradename 28525 28531	BEXXAR
T401	tradename 28757 28763	BEXXAR
T403	tradename 28861 28867	BEXXAR
T405	tradename 29433 29439	BEXXAR
T407	tradename 29652 29658	BEXXAR
T409	tradename 29769 29775	BEXXAR
T411	tradename 30030 30036	BEXXAR
T413	tradename 30284 30290	BEXXAR
T415	tradename 30364 30370	BEXXAR
T417	activeingredient 30458 30477	radiolabeled iodine
T419	nanoparticle 30626 30644	I-131 tositumomab.
T421	tradename 30821 30827	BEXXAR
T423	tradename 30898 30904	BEXXAR
T425	tradename 31088 31098	BEXXAR.  
T427	adversereaction 31225 31251	Serious Allergic Reactions
T429	adversereaction 31263 31274	Anaphylaxis
T431	adversereaction 31327 31358	Prolonged and Severe Cytopenias
T433	adversereaction 31458 31472	Hypothyroidism
T435	tradename 31572 31578	BEXXAR
T437	adversereaction 31645 31656	neutropenia
T439	adversereaction 31658 31674	thrombocytopenia
T441	adversereaction 31676 31682	anemia
T443	adversereaction 31685 31695	infections
T445	adversereaction 31707 31716	pneumonia
T447	adversereaction 31718 31728	bacteremia
T449	adversereaction 31730 31740	septicemia
T451	adversereaction 31742 31752	bronchitis
T453	adversereaction 31758 31774	skin infections)
T455	adversereaction 31777 31795	infusion reactions
T457	adversereaction 31797 31805	asthenia
T459	adversereaction 31807 31812	fever
T461	adversereaction 31818 31824	nausea
T463	tradename 31952 31958	BEXXAR
T465	adversereaction 31984 32015	severe and prolonged cytopenias
T467	adversereaction 32017 32027	infections
T469	adversereaction 32039 32048	pneumonia
T471	adversereaction 32050 32060	bacteremia
T473	adversereaction 32062 32072	septicemia
T475	adversereaction 32074 32084	bronchitis
T477	adversereaction 32090 32106	skin infections)
T479	adversereaction 32108 32134	serious allergic reactions
T481	adversereaction 32146 32158	bronchospasm
T483	adversereaction 32163 32174	angioedema)
T485	adversereaction 32176 32194	infusion reactions
T487	adversereaction 32200 32218	secondary leukemia
T489	adversereaction 32224 32248	myelodysplastic syndrome
T491	tradename 32670 32676	BEXXAR
T493	indication 32718 32740	non-Hodgkin's lymphoma
T495	tradename 33959 33965	BEXXAR
T497	adversereaction 34085 34093	Asthenia
T499	adversereaction 34101 34106	Fever
T501	adversereaction 34116 34125	Infection
T503	adversereaction 34138 34142	Pain
T505	adversereaction 34151 34157	Chills
T507	adversereaction 34166 34174	Headache
T509	adversereaction 34184 34198	Abdominal pain
T511	adversereaction 34208 34217	Back pain
T513	adversereaction 34226 34236	Chest pain
T515	adversereaction 34245 34254	Neck pain
T517	adversereaction 34293 34304	Hypotension
T519	adversereaction 34312 34326	Vasodilatation
T521	adversereaction 34360 34366	Nausea
T523	adversereaction 34376 34384	Vomiting
T525	adversereaction 34393 34401	Anorexia
T527	adversereaction 34410 34418	Diarrhea
T529	adversereaction 34427 34439	Constipation
T531	adversereaction 34447 34456	Dyspepsia
T533	adversereaction 34493 34507	Hypothyroidism
T535	tradename 34515 34516	 
T537	adversereaction 34516 34551	Metabolic and Nutritional Disorders
T539	adversereaction 34560 34576	Peripheral edema
T541	adversereaction 34585 34596	Weight loss
T543	adversereaction 34640 34647	Myalgia
T545	adversereaction 34661 34674	Arthralgia 10
T547	adversereaction 34704 34713	Dizziness
T549	adversereaction 34722 34732	Somnolence
T551	adversereaction 34769 34784	Cough increased
T553	adversereaction 34793 34804	Pharyngitis
T555	adversereaction 34813 34820	Dyspnea
T557	adversereaction 34829 34837	Rhinitis
T559	adversereaction 34847 34856	Pneumonia
T561	adversereaction 34893 34897	Rash
T563	adversereaction 34910 34918	Pruritus
T565	adversereaction 34927 34935	Sweating
T567	tradename 36450 36451	 
T569	adversereaction 36451 36483	Prolonged and Severe Cytopenias:
T571	tradename 36838 36839	 
T573	adversereaction 36839 36850	Infections:
T575	adversereaction 36986 36995	pneumonia
T577	adversereaction 36997 37007	bacteremia
T579	adversereaction 37010 37020	septicemia
T581	adversereaction 37022 37032	bronchitis
T583	adversereaction 37038 37094	skin infections. Allergic (Hypersensitivity) Reactions:
T585	adversereaction 37182 37199	allergic reaction
T587	adversereaction 37201 37213	facial edema
T589	adversereaction 37215 37246	injection site hypersensitivity
T591	adversereaction 37249 37270	anaphylactic reaction
T593	adversereaction 37272 37283	laryngismus
T595	adversereaction 37289 37304	serum sickness.
T597	adversereaction 37342 37360	Infusion reactions
T599	adversereaction 37371 37376	fever
T601	adversereaction 37378 37384	rigors
T603	adversereaction 37388 37394	chills
T605	adversereaction 37397 37405	sweating
T607	adversereaction 37407 37418	hypotension
T609	adversereaction 37420 37427	dyspnea
T611	adversereaction 37429 37441	bronchospasm
T613	adversereaction 37447 37453	nausea
T615	tradename 37724 37725	 
T617	adversereaction 37725 37749	Myelodysplastic Syndrome
T619	adversereaction 37756 37775	Secondary Leukemia:
T621	nanoparticle 39643 39655	tositumomab.
T623	indication 40198 40220	Non-Hodgkin's Lymphoma
T625	tradename 40235 40241	BEXXAR
T627	indication 40562 40584	non-Hodgkin's lymphoma
T629	tradename 40602 40608	BEXXAR
T631	tradename 41026 41032	BEXXAR
T633	tradename 41221 41227	BEXXAR
T635	nanoparticle 41694 41705	tositumomab
T637	nanoparticle 41709 41731	I-131 499 tositumomab.
T639	tradename 41869 41875	BEXXAR
T641	tradename 41996 42002	BEXXAR
T643	activeingredient 42210 42215	I-131
T645	tradename 42290 42296	BEXXAR
T647	tradename 42407 42413	BEXXAR
T649	nanoparticle 42608 42619	tositumomab
T651	tradename 42870 42876	BEXXAR
T653	tradename 43014 43020	BEXXAR
T655	tradename 43113 43119	BEXXAR
T657	tradename 43227 43233	BEXXAR
T659	tradename 43429 43435	BEXXAR
T661	tradename 43745 43751	BEXXAR
T663	tradename 43937 43943	BEXXAR
T665	tradename 44191 44197	BEXXAR
T667	tradename 44277 44283	BEXXAR
T669	activeingredient 44424 44429	I-131
T671	tradename 44435 44441	BEXXAR
T673	activeingredient 44648 44653	I-131
T675	tradename 44671 44677	BEXXAR
T677	tradename 44960 44966	BEXXAR
T679	tradename 45011 45017	BEXXAR
T681	nanoparticle 45077 45088	tositumomab
T683	nanoparticle 45132 45150	I-131 tositumomab.
T685	nanoparticle 45152 45163	Tositumomab
T687	nanoparticle 45310 45321	tositumomab
T689	molecularweight 45325 45332	150 kD.
T691	nanoparticle 45335 45346	Tositumomab
T693	routeofadministration 45493 45504	intravenous
T695	inactiveingredient 45556 45563	maltose
T697	inactiveingredient 45575 45590	sodium chloride
T699	inactiveingredient 45600 45609	phosphate
T701	inactiveingredient 45619 45638	potassium hydroxide
T703	inactiveingredient 45644 45649	Water
T705	nanoparticle 45701 45718	I-131 tositumomab
T707	nanoparticle 45722 45733	tositumomab
T709	activeingredient 45755 45766	Iodine-131.
T711	nanoparticle 45767 45784	I-131 tositumomab
T713	nanoparticle 45865 45882	I-131 tositumomab
T715	inactiveingredient 45909 45922	ascorbic acid
T717	inactiveingredient 45937 45944	maltose
T719	inactiveingredient 45980 45987	maltose
T721	inactiveingredient 46027 46035	povidone
T723	inactiveingredient 46058 46078	sodium 568 chloride.
T725	activeingredient 46158 46180	Iodine-131: Iodine-131
T727	activeingredient 46435 46445	Iodine-131
T729	activeingredient 46646 46656	Iodine-131
T731	activeingredient 46822 46833	Iodine-131:
T733	activeingredient 47079 47090	Tositumomab
T735	indication 47296 47320	non-Hodgkin's lymphomas.
T737	tradename 47431 47437	BEXXAR
T739	tradename 47900 47906	BEXXAR
T741	tradename 48577 48583	BEXXAR
T743	nanoparticle 48695 48712	I-131 tositumomab
T745	dose 48731 48737	475-mg
T747	dose 48918 48924	485 mg
T749	nanoparticle 48928 48939	tositumomab
T751	indication 48961 48984	non-Hodgkin's lymphomas
T753	clearance 48989 48999	68.2 mg/hr
T755	clearance 49008 49032	30.2 to 611 260.8 mg/hr)
T757	indication 49687 49709	non-Hodgkin's lymphoma
T759	eliminationhalflife 49714 49722	67 hours
T761	eliminationhalflife 49731 49747	28 to 115 hours)
T763	activeingredient 49766 49776	Iodine-131
T765	tradename 50193 50199	BEXXAR
T767	activeingredient 50292 50304	Iodine I-131
T769	tradename 50368 50374	BEXXAR
T771	tradename 50534 50540	BEXXAR
T773	tradename 51856 51862	BEXXAR
T775	indication 52512 52534	non-Hodgkin's lymphoma
T777	tradename 52811 52817	BEXXAR
T779	nanoparticle 53423 53434	tositumomab
T781	nanoparticle 53562 53580	I-131 tositumomab
T783	nanoparticle 53863 53874	tositumomab
T785	nanoparticle 54022 54041	677 131 tositumomab
T787	nanoparticle 54169 54181	Tositumomab:
T789	nanoparticle 54223 54234	tositumomab
T791	nanoparticle 54355 54366	tositumomab
T793	nanoparticle 54505 54523	I-131 tositumomab:
T795	nanoparticle 54539 54556	I-131 tositumomab
T797	nanoparticle 54706 54723	I-131 tositumomab
T799	nanoparticle 54832 54849	I-131 tositumomab
T801	tradename 55849 55855	BEXXAR
T803	tradename 56092 56098	BEXXAR
T805	tradename 56477 56483	BEXXAR
T807	tradename 56589 56595	BEXXAR
T809	tradename 56664 56670	BEXXAR
T811	company 56700 56716	GlaxoSmithKline.
T813	company 56792 56807	GlaxoSmithKline
T815	company 56879 56895	GlaxoSmithKline.
